5‐Hydroxytryptamine and Atrial Fibrillation:
- 1 February 2003
- journal article
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 14 (2) , 209-214
- https://doi.org/10.1046/j.1540-8167.2003.02381.x
Abstract
No abstract availableKeywords
This publication has 86 references indexed in Scilit:
- 5-Hydroxytryptamine: a chameleon in the heartTrends in Pharmacological Sciences, 1991
- Acute electrophysiologic effects of an HT2-serotonin antagonist, ketanserin, in humansCardiovascular Drugs and Therapy, 1990
- Platelet serotonin decrease in alcoholic patientsActa Psychiatrica Scandinavica, 1990
- Kinetics of serotonin in platelets in essential hypertensionLife Sciences, 1990
- Incidence and clinical relevance of QT prolongation caused by the new selective serotonin antagonist ketanserinThe American Journal of Cardiology, 1989
- Serotoninergic mechanisms in hypertension. Focus on the effects of ketanserin.Hypertension, 1988
- Study of in vivo platelet activation in uncomplicated essential hypertensionLife Sciences, 1987
- Blood platelets in human essential hypertensionInflammation Research, 1986
- Atrial fibrillation as a self-sustaining arrhythmia independent of focal dischargeAmerican Heart Journal, 1959
- Serotonin and AntiserotoninsCirculation, 1957